Activation of hepatic stellate cells--a key issue in liver fibrosis.
暂无分享,去创建一个
[1] K. S. Lee,et al. Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. , 1995, The Journal of clinical investigation.
[2] A. Gressner,et al. Induction of neutrophil-attracting chemokines in transforming rat hepatic stellate cells. , 1997, Gastroenterology.
[3] G. Brittenham,et al. Experimental liver cirrhosis induced by alcohol and iron. , 1995, The Journal of clinical investigation.
[4] E. Tekle,et al. Epidermal Growth Factor (EGF)-induced Generation of Hydrogen Peroxide , 1997, The Journal of Biological Chemistry.
[5] J. Massagué,et al. Transcriptional control by the TGF‐β/Smad signaling system , 2000 .
[6] L. Gesualdo,et al. Regulation of macrophage colony-stimulating factor in liver fat-storing cells by peptide growth factors. , 1992, The American journal of physiology.
[7] G. Davis,et al. Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders. , 2000, Gastroenterology.
[8] S. Nakanishi,et al. Cloning and expression of a cDNA encoding an endothelin receptor , 1990, Nature.
[9] S. Friedman,et al. CYP2E1‐mediated oxidative stress induces collagen type I expression in rat hepatic stellate cells , 1999, Hepatology.
[10] M. Yanagisawa,et al. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[11] Peter Schirmacher,et al. Hepatocyte growth factor/hepatopoietin A is expressed in fat‐storing cells from rat liver but not myofibroblast‐like cells derived from fat‐storing cells , 1992, Hepatology.
[12] L. Gesualdo,et al. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. , 1989, The Journal of clinical investigation.
[13] H. Popper,et al. Capillarization of hepatic sinusoids in man. , 1963, Gastroenterology.
[14] D. Aron,et al. Secretion of insulin-like growth factor-I and binding proteins by rat liver fat-storing cells: regulatory role of platelet-derived growth factor. , 1990, Endocrinology.
[15] S. Friedman,et al. Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix. , 1989, The Journal of biological chemistry.
[16] M. Arthur,et al. The plasminogen‐activating system in hepatic stellate cells , 1996, Hepatology.
[17] J. Egido,et al. Overexpression of extracellular matrix proteins in renal tubulointerstitial cells by platelet-activating-factor stimulation. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[18] G. Poli. Pathogenesis of liver fibrosis: role of oxidative stress. , 2000, Molecular aspects of medicine.
[19] N. Hayashi,et al. Improvement of liver fibrosis in chronic hepatitis C patients treated with natural interferon alpha. , 1995, Journal of hepatology.
[20] H. Tsukamoto,et al. Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease , 1995, Hepatology.
[21] P. Desmond,et al. Sequential increases in the intrahepatic expression of epidermal growth factor, basic fibroblast growth factor, and transforming growth factor β in a bile duct ligated rat model of cirrhosis , 1997, Hepatology.
[22] G. Zimmerman,et al. Platelet-activating factor and related lipid mediators. , 2000, Annual review of biochemistry.
[23] C. Lieber,et al. Acetaldehyde selectively stimulates collagen production in cultured rat liver fat‐storing cells but not in hepatocytes , 1990, Hepatology.
[24] D. Rockey. The cellular pathogenesis of portal hypertension: Stellate cell contractility, endothelin, and nitric oxide , 1997, Hepatology.
[25] S. Wahl,et al. In situ expression of transforming growth factor beta in streptococcal cell wall-induced granulomatous inflammation and hepatic fibrosis. , 1990, Growth factors.
[26] M. Czaja,et al. Ito cell expression of a nuclear retinoic acid receptor , 1992, Hepatology.
[27] J. Wrana,et al. Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta. , 1989, The Journal of biological chemistry.
[28] V. Paradis,et al. In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features. , 1997, Journal of clinical pathology.
[29] Sadao Kimura,et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.
[30] A. J. Valente,et al. Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines. , 1993, The Journal of clinical investigation.
[31] P. Heinrich,et al. Induction of rat α2‐macroglobulin in vivo and in hepatocyte primary cultures: synergistic action of glucocorticoids and a Kupffer cell‐derived factor , 1984, FEBS letters.
[32] A. Cederbaum. Introduction: role of lipid peroxidation and oxidative stress in alcohol toxicity , 1989 .
[33] J. Witztum,et al. Excess iron induces hepatic oxidative stress and transforming growth factor β1 in genetic hemochromatosis , 1997, Hepatology.
[34] M. Arthur,et al. Increased expression of connective tissue growth factor in fibrotic human liver and in activated hepatic stellate cells. , 2000, Journal of hepatology.
[35] Cho-il Kim,et al. S‐Adenosyl‐L‐methionine attenuates alcohol‐induced liver injury in the baboon , 1990, Hepatology.
[36] A Geerts,et al. History, Heterogeneity, Developmental Biology, and Functions of Quiescent Hepatic Stellate Cells , 2001, Seminars in liver disease.
[37] G. Dubyak,et al. Mitogenic signals for platelet-derived growth factor isoforms in liver fat-storing cells. , 1991, The American journal of physiology.
[38] P. Muriel,et al. Dose-response studies of interferon-alpha 2b on liver fibrosis and cholestasis induced by biliary obstruction in rats. , 1997, Pharmacology.
[39] J. Prieto,et al. Randomised trial of lymphoblastoid alpha-interferon in chronic hepatitis C. Effects on inflammation, fibrogenesis and viremia. , 1993, Journal of hepatology.
[40] R. Hammer,et al. Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice. , 1997, The Journal of clinical investigation.
[41] S. Milani,et al. Expression of platelet‐derived growth factor in a model of acute liver injury , 1994, Hepatology.
[42] T. Kitamoto,et al. Increased 9,13-di-cis-retinoic acid in rat hepatic fibrosis: implication for a potential link between retinoid loss and TGF-beta mediated fibrogenesis in vivo. , 1999, Journal of hepatology.
[43] Pieter,et al. Insulin‐like growth factor II/mannose 6‐phosphate‐receptor expression in liver and serum during acute CCl4 intoxication in the rat , 1996, Hepatology.
[44] H. Reeves,et al. Stress-activated protein kinases in the activation of rat hepatic stellate cells in culture. , 2000, Journal of hepatology.
[45] Anping Chen,et al. Platelet-derived growth factor is a principal inductive factormodulating mannose 6-phosphate/insulin-like growth factor-II receptorgene expression via a distal E-box in activated hepatic stellate cells. , 2000, The Biochemical journal.
[46] K. Nose,et al. Production of hydrogen peroxide by transforming growth factor-beta 1 and its involvement in induction of egr-1 in mouse osteoblastic cells , 1994, The Journal of cell biology.
[47] S. Friedman,et al. Hepatic lipocytes: a major target for endothelin-1. , 1995, Journal of hepatology.
[48] D. Leroith. Insulin-like growth factor receptors and binding proteins. , 1996, Bailliere's clinical endocrinology and metabolism.
[49] M. Rugge,et al. Liver stellate cells in chronic viral hepatitis: the effect of interferon therapy. , 1996, Journal of hepatology.
[50] A. Gressner,et al. Hepatocyte-conditioned medium potentiates insulin-like growth factor (IGF) 1 and 2 stimulated DNA synthesis of cultured fat storing cells. , 2008, Liver.
[51] S. Strömblad,et al. The coupling between transforming growth factor-alpha and the epidermal growth factor receptor during rat liver regeneration. , 1993, Experimental cell research.
[52] F. Weiner,et al. Increased transforming growth factor-β1 gene expression in human liver disease , 1992 .
[53] R. Rippe,et al. Expression of Interleukin-10 by in Vitro and in Vivo Activated Hepatic Stellate Cells* , 1998, The Journal of Biological Chemistry.
[54] M. Czaja,et al. In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis , 1989, The Journal of cell biology.
[55] H. Herbst,et al. Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis. , 1996, The American journal of pathology.
[56] D. Brenner,et al. The role of Smad3 in mediating mouse hepatic stellate cell activation , 2001, Hepatology.
[57] H. Senoo,et al. Morphology of sites of adhesion between hepatic stellate cells (vitamin A‐storing cells) and a three‐dimensional extracellular matrix , 1998, The Anatomical record.
[58] M. Arthur. Iron overload and liver fibrosis , 1996, Journal of gastroenterology and hepatology.
[59] S. Milani,et al. Expression of the thrombin receptor in human liver: Up‐regulation during acute and chronic injury , 1998, Hepatology.
[60] L. Kaplan. Leptin, obesity, and liver disease. , 1998, Gastroenterology.
[61] A. Gentilini,et al. Phosphatidylinositol-3 kinase and extracellular signal-regulated kinase mediate the chemotactic and mitogenic effects of insulin-like growth factor-I in human hepatic stellate cells. , 2000, Journal of hepatology.
[62] Anping Chen,et al. The DNA Binding Protein BTEB Mediates Acetaldehyde-Induced, Jun N-Terminal Kinase-Dependent αI(I) Collagen Gene Expression in Rat Hepatic Stellate Cells , 2000, Molecular and Cellular Biology.
[63] H. Tsukamoto,et al. Diminished retinoic acid signaling in hepatic stellate cells in cholestatic liver fibrosis. , 1997, The American journal of physiology.
[64] M. Olive,et al. Tumor Necrosis Factor Alpha Inhibits Type I Collagen Synthesis through Repressive CCAAT/Enhancer-Binding Proteins , 2000, Molecular and Cellular Biology.
[65] F. Anania,et al. Transdifferentiation of rat hepatic stellate cells results in leptin expression. , 1998, Biochemical and biophysical research communications.
[66] S. Kojima,et al. Retinoids exacerbate rat liver fibrosis by inducing the activation of latent TGF‐β in liver stellate cells , 1997 .
[67] K. Decker,et al. Regulation of the mRNA expression for tumor necrosis factor-α in rat liver macrophages , 1994 .
[68] H. Tsukamoto,et al. Stimulation of hepatic lipocyte collagen production by Kupffer cell‐derived transforming growth factor β: Implication for a pathogenetic role in alcoholic liver fibrogenesis , 1990, Hepatology.
[69] A. Gressner,et al. Liver fat storing cell proliferation is stimulated by epidermal growth factor/transforming growth factor alpha and inhibited by transforming growth factor beta. , 1989, Biochemical and biophysical research communications.
[70] V. Desmet,et al. Distribution of the VLA family of integrins in normal and pathological human liver tissue. , 1991, Gastroenterology.
[71] D. Robyr,et al. Nuclear hormone receptor coregulators in action: diversity for shared tasks. , 2000, Molecular endocrinology.
[72] N. Davidson,et al. Retinoic acid and transforming growth factor beta differentially inhibit platelet-derived-growth-factor-induced Ito-cell activation. , 1991, The Biochemical journal.
[73] S. Friedman,et al. Secretion of 72 kDa type IV collagenase/gelatinase by cultured human lipocytes. Analysis of gene expression, protein synthesis and proteinase activity. , 1992, The Biochemical journal.
[74] V. Paradis,et al. In situ detection of lipid peroxidation by‐products in chronic liver diseases , 1997, Hepatology.
[75] F. Marra,et al. Cytokine Receptors and Signaling in Hepatic Stellate Cells , 2001, Seminars in liver disease.
[76] A. Gentilini,et al. Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen alpha 1 (I) gene expression in human liver fat-storing cells. , 1993, Biochemical and biophysical research communications.
[77] Y. Takei,et al. Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals , 2001, Hepatology.
[78] A. Gressner,et al. Effects of murine recombinant interferon-gamma on rat liver fat storing cell proliferation, cluster formation and proteoglycan synthesis. , 1990, Biochemical pharmacology.
[79] D M Bissell,et al. The role of alpha1beta1 integrin in wound contraction. A quantitative analysis of liver myofibroblasts in vivo and in primary culture. , 1997, The Journal of biological chemistry.
[80] D. Crabb,et al. The role of hepatic peroxisome proliferator-activated receptors (PPARs) in health and disease. , 2000, Liver.
[81] A. Casini,et al. Acetaldehyde-protein adducts, but not lactate and pyruvate, stimulate gene transcription of collagen and fibronectin in hepatic fat-storing cells. , 1993, Journal of hepatology.
[82] V. Carloni,et al. Biosynthesis of platelet-activating factor and its 1O-acyl analogue by liver fat-storing cells. , 1994, Gastroenterology.
[83] D. Rockey,et al. Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: implications for treatment of hepatic fibrosis. , 1994, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.
[84] S. Milani,et al. Transforming growth factor‐β1 regulates platelet‐derived growth factor receptor β subunit in human liver fat‐storing cells , 1995 .
[85] E. Wisse,et al. Insulinlike growth factor—ii/mannose 6‐phosphate receptor is expressed on ccl4‐exposed rat fat‐storing cells and facilitates activation of latent transforming growth factor‐β in cocultures with sinusoidal endothelial cells , 1995 .
[86] J. Maher,et al. Support of cultured hepatocytes by a laminin-rich gel. Evidence for a functionally significant subendothelial matrix in normal rat liver. , 1987, The Journal of clinical investigation.
[87] Jeffrey L. Wrana,et al. Mechanism of activation of the TGF-β receptor , 1994, Nature.
[88] R. Derynck. The Physiology Of Transforming Growth Factor-α , 1992 .
[89] S. Milani,et al. Regulation of extracellular matrix synthesis by transforming growth factor beta 1 in human fat-storing cells. , 1993, Gastroenterology.
[90] G. Ramadori,et al. Effect of tumour necrosis factor-alpha on proliferation, activation and protein synthesis of rat hepatic stellate cells. , 1997, Journal of hepatology.
[91] T. Finkel. Oxygen radicals and signaling. , 1998, Current opinion in cell biology.
[92] J. Iredale. Hepatic Stellate Cell Behavior during Resolution of Liver Injury , 2001, Seminars in liver disease.
[93] M. Vidaud,et al. Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc Group. , 1999, Gastroenterology.
[94] M. Buck,et al. LAP (NF-IL6) transactivates the collagen alpha 1(I) gene from a 5' regulatory region. , 1994, The Journal of clinical investigation.
[95] C. Lieber,et al. Hepatic vitamin A depletion after chronic ethanol consumption in baboons and rats. , 1981, The Journal of nutrition.
[96] M J Banda,et al. Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping. , 1988, Science.
[97] S. Pestka. The human interferon alpha species and receptors. , 2000, Biopolymers.
[98] H. Abboud,et al. Regulation of platelet-derived growth factor secretion and gene expression in human liver fat-storing cells. , 1994, Gastroenterology.
[99] C. Lieber,et al. Acetaldehyde increases procollagen type I and fibronectin gene transcription in cultured rat fat‐storing cells through a protein synthesis–dependent mechanism , 1991, Hepatology.
[100] D. Dhumeaux,et al. Interferon alfa and gamma inhibit proliferation and collagen synthesis of human ito cells in culture , 1995, Hepatology.
[101] D. Rockey,et al. Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis , 1994, The Journal of cell biology.
[102] C. S. Gal,et al. Growth inhibitory properties of endothelin-1 in human hepatic myofibroblastic Ito cells. An endothelin B receptor-mediated pathway. , 1995, The Journal of clinical investigation.
[103] F. Ridolfi,et al. Fibrogenic effect of oxidative stress on rat hepatic stellate cells , 1998, Hepatology.
[104] J. Saklatvala,et al. Interleukin-1 inhibits the synthesis of collagen by fibroblasts. , 1986, Biochemistry international.
[105] M. Ziol,et al. A histopathological study of the effects of 6-month versus 12-month interferon alpha-2b therapy in chronic hepatitis C. , 1996, Journal of Hepatology.
[106] M. Chojkier,et al. A pilot study of the effects of d-alpha-tocopherol on hepatic stellate cell activation in chronic hepatitis C. , 1997, Gastroenterology.
[107] J. Heath,et al. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. , 1987, The EMBO journal.
[108] D. Rockey,et al. Regulation of Endothelin-1 Synthesis by Endothelin-converting Enzyme-1 during Wound Healing* , 1999, The Journal of Biological Chemistry.
[109] D. Rifkin,et al. Requirement for receptor‐bound urokinase in plasmin‐dependent cellular conversion of latent TGF‐β to TGF‐β , 1994 .
[110] A. Casini,et al. Acetaldehyde induces c-fos and c-jun proto-oncogenes in fat-storing cell cultures through protein kinase C activation. , 1994, Alcohol and alcoholism.
[111] R. F. McGuire,et al. Role of extracellular matrix in regulating fenestrations of sinusoidal endothelial cells isolated from normal rat liver , 1992, Hepatology.
[112] V. Paradis,et al. Expression of connective tissue growth factor in experimental rat and human liver fibrosis , 1999, Hepatology.
[113] V. Rogiers,et al. Transforming growth factor-β gene expression in normal and fibrotic rat liver , 1997 .
[114] B. Halliwell,et al. Free radicals in biology and medicine , 1985 .
[115] D. Schuppan,et al. Kupffer cell–derived 95‐kd type IV collagenase/gelatinase B: Characterization and expression in cultured cells , 1995, Hepatology.
[116] A. Rosman,et al. Differential depletion of carotenoids and tocopherol in liver disease , 1993, Hepatology.
[117] H. Nakshatri,et al. The Platelet-activating Factor Receptor Protects Epidermal Cells from Tumor Necrosis Factor (TNF) α and TNF-related Apoptosis-inducing Ligand-induced Apoptosis through an NF-κB-dependent Process* , 2001, The Journal of Biological Chemistry.
[118] C. Lieber,et al. Hepatic Fibrosis After Long‐Term Administration of Ethanol and Moderate Vitamin A Supplementation in the Rat , 2007, Hepatology.
[119] S. Friedman,et al. Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture. , 1994, The Journal of clinical investigation.
[120] D. Rockey,et al. Cellular localization of endothelin‐1 and increased production in liver injury in the rat: Potential for autocrine and paracrine effects on stellate cells , 1998, Hepatology.
[121] J. Friedman,et al. Obesity in the new millennium , 2000, Nature.
[122] D. Brenner,et al. The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo. , 1999, Journal of hepatology.
[123] P. Greenwel,et al. Characterization of fat-storing cell lines derived from normal and CCl4-cirrhotic livers. Differences in the production of interleukin-6. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[124] L. Videla,et al. Content of hepatic reduced glutathione in chronic alcoholic patients: influence of the length of abstinence and liver necrosis. , 1984, Clinical science.
[125] Wei Wu,et al. Interleukin‐10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice , 1998, Hepatology.
[126] G. Svegliati-Baroni,et al. Intracellular signaling pathways involved in acetaldehyde‐induced collagen and fibronectin gene expression in human hepatic stellate cells , 2001, Hepatology.
[127] P. Marcellin,et al. Changes in liver fibrosis at the end of alpha interferon therapy and 6 to 18 months later in patients with chronic hepatitis C: quantitative assessment by a morphometric method. , 1998, Journal of hepatology.
[128] A. Gressner,et al. The response of rat liver perisinusoidal lipocytes to polypeptide growth regulator changes with their transdifferentiation into myofibroblast-like cells in culture. , 1993, Journal of hepatology.
[129] M. Shibuya,et al. Inhibition of hepatic stellate cell contraction during activation in vitro by vascular endothelial growth factor in association with upregulation of FLT tyrosine kinase receptor family, FLT-1. , 1999, Biochemical and biophysical research communications.
[130] J. Rosenbloom,et al. Selective inhibition of human diploid fibroblast collagen synthesis by interferons. , 1984, The Journal of clinical investigation.
[131] K. Tsuneyama,et al. Histopathology of Primary Biliary Cirrhosis with Emphasis on Expression of Adhesion Molecules , 1997, Seminars in liver disease.
[132] S. Friedman,et al. Coordinated induction of VEGF receptors in mesenchymal cell types during rat hepatic wound healing , 1998, Oncogene.
[133] A. Gressner,et al. A cascade-mechanism of fat storing cell activation forms the basis of the fibrogenic reaction of the liver. , 1995, Verhandlungen der Deutschen Gesellschaft fur Pathologie.
[134] R W Alexander,et al. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. , 1994, Circulation research.
[135] A. Benedetti,et al. Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis , 1996, Hepatology.
[136] A. Nanji,et al. Intercellular Adhesion Molecule-1 Expression in Experimental Alcoholic Liver Disease: Relationship to Endotoxemia and TNFα Messenger RNA , 1995 .
[137] D M Bissell,et al. Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation. , 1995, The Journal of clinical investigation.
[138] S. Thorgeirsson,et al. Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. , 1990, The Journal of clinical investigation.
[139] K. Wake,et al. Suppression of experimental hepatic fibrosis by administration of vitamin A. , 1985, Laboratory investigation; a journal of technical methods and pathology.
[140] C. Lieber,et al. Hepatotoxicity of vitamin A and ethanol in the rat. , 1982, Gastroenterology.
[141] S. Friedman,et al. Inhibition of rat hepatic lipocyte activation in culture by interferon‐γ , 1992, Hepatology.
[142] E. Mezey,et al. Identification of new sites of binding and activation of the murine α1(I) collagen promoter by CCAAT/enhancer binding protein β , 2001 .
[144] A. Gressner,et al. Bidirectional effects of Kupffer cells on hepatocyte proliferation in vitro , 1991, FEBS letters.
[145] B. Bacon,et al. Hepatic lipid peroxidation in hereditary hemochromatosis and alcoholic liver injury. , 1999, The Journal of laboratory and clinical medicine.
[146] B. Bacon,et al. Effect of vitamin E supplementation on hepatic fibrogenesis in chronic dietary iron overload. , 1997, The American journal of physiology.
[147] Yun Wang,et al. Hypoxic stimulation of vascular endothelial growth factor expression in activated rat hepatic stellate cells , 2000, Hepatology.
[148] T. Izumi,et al. Role of PAF in Acute Liver Injury After Extended Hepatectomy , 2001, Digestive Diseases and Sciences.
[149] R. Mason,et al. Free radicals in toxicology. , 1993, Toxicology and applied pharmacology.
[150] D. Hanahan,et al. Biosynthesis of platelet-activating factor by cultured rat Kupffer cells stimulated with calcium ionophore A23187. , 1989, The Biochemical journal.
[151] C. Lieber,et al. Hepatic vitamin A depletion in alcoholic liver injury. , 1982, The New England journal of medicine.
[152] F. Oberti,et al. Effects of long-term administration of interferon α in two models of liver fibrosis in rats , 1998 .
[153] S. Friedman,et al. Lipocytes from normal rat liver release a neutral metalloproteinase that degrades basement membrane (type IV) collagen. , 1989, The Journal of clinical investigation.
[154] S. Milani,et al. Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. , 1996, Gastroenterology.
[155] S. Milani,et al. Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. , 1998, The American journal of pathology.
[156] N. Davidson,et al. Retinoic acid modulates rat Ito cell proliferation, collagen, and transforming growth factor beta production. , 1990, The Journal of clinical investigation.
[157] D. Adams,et al. Expression of E‐selectin and E‐selectin ligands in human liver inflammation , 1996, Hepatology.
[158] I. Hernández-Muñoz,et al. Tumor necrosis factor alpha inhibits collagen alpha 1(I) gene expression in rat hepatic stellate cells through a G protein. , 1997, Gastroenterology.
[159] B. Bacon,et al. Fibronectin and cytokines increase JNK, ERK, AP-1 activity, and transin gene expression in rat hepatic stellate cells. , 1997, American journal of physiology. Gastrointestinal and liver physiology.
[160] R. Ross,et al. Two classes of PDGF receptor recognize different isoforms of PDGF. , 1988, Science.
[161] D. Rockey,et al. Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[162] J. Iredale,et al. Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors , 2001, Gut.
[163] V. Carloni,et al. Expression and function of integrin receptors for collagen and laminin in cultured human hepatic stellate cells. , 1995, Gastroenterology.
[164] J. Ward,et al. Collaboration between growth factors and diverse chemical carcinogens in hepatocarcinogenesis of transforming growth factor alpha transgenic mice. , 1993, Cancer research.
[165] V. Carloni,et al. Focal adhesion kinase and phospholipase C gamma involvement in adhesion and migration of human hepatic stellate cells. , 1997, Gastroenterology.
[166] J. Seyer,et al. Transcriptional mechanisms of type I collagen gene expression are differentially regulated by interleukin-1 beta, tumor necrosis factor alpha, and transforming growth factor beta in Ito cells. , 1992, Journal of Biological Chemistry.
[167] K. Mak,et al. Alcoholic liver injury in baboons: transformation of lipocytes to transitional cells. , 1984, Gastroenterology.
[168] G. Habermehl,et al. Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-alpha. , 1989, The Biochemical journal.
[169] D. Rockey,et al. Endothelin antagonism in experimental hepatic fibrosis. Implications for endothelin in the pathogenesis of wound healing. , 1996, The Journal of clinical investigation.
[170] M. Arthur,et al. Primary rat and mouse hepatic stellate cells express the macrophage inhibitor cytokine interleukin‐10 during the course of activation in vitro , 1998, Hepatology.
[171] P. Muriel,et al. Remission of liver fibrosis by interferon-α2b , 1995 .
[172] D. Rifkin,et al. TGF‐β Latency: Biological Significance and Mechanisms of Activation , 1997 .
[173] M. Sporn,et al. Induction of transforming growth factor-α in activated human alveolar macrophages , 1988, Cell.
[174] S. Friedman,et al. Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors. , 1989, The Journal of clinical investigation.
[175] A. Pietrangelo. Iron, oxidative stress and liver fibrogenesis. , 1998, Journal of hepatology.
[176] R. Chamuleau,et al. Collagen synthesis by human liver (myo)fibroblasts in culture: evidence fora regulatory role of IL-1β,IL-4, TGFβ and IFN gamma , 1995 .
[177] S. Strömblad,et al. Increased expression of and sensitivity to transforming growth factor‐α: A promotive role during rat liver carcinogenesis , 1994, Molecular carcinogenesis.
[178] D. Bissell. Hepatic fibrosis as wound repair: A progress report , 1998, Journal of Gastroenterology.
[179] B. Neuschwander‐Tetri,et al. Manipulation of glutathione stores in rat hepatic stellate cells does not alter collagen synthesis , 1997, Hepatology.
[180] M. Lerner,et al. Cloning and characterization of an endothelin-3 specific receptor (ETC receptor) from Xenopus laevis dermal melanophores. , 1993, The Journal of biological chemistry.
[181] D. Adams,et al. Endothelial activation and circulating vascular adhesion molecules in alcoholic liver disease , 1994, Hepatology.
[182] A. Burt,et al. In vivo responses of macrophages and perisinusoidal cells to cholestatic liver injury. , 1993, The American journal of pathology.
[183] H. Hendriks,et al. Fat-Storing Cells: Hyper- and Hypovitaminosis A and the Relationships with Liver Fibrosis , 1993, Seminars in liver disease.
[184] R. Burk,et al. Relationship of oxygen and glutathione in protection against carbon tetrachloride-induced hepatic microsomal lipid peroxidation and covalent binding in the rat. Rationale for the use of hyperbaric oxygen to treat carbon tetrachloride ingestion. , 1984, The Journal of clinical investigation.
[185] E. Mezey,et al. CCAAT/Enhancer Binding Protein β Mediates the Activation of the Murine α1(I) Collagen Promoter by Acetaldehyde , 2000 .
[186] M. Arthur,et al. Rat hepatic lipocytes synthesize and secrete transin (stromelysin) in early primary culture. , 1995, Gastroenterology.
[187] G. Ramadori,et al. Characterization of the IGF axis components in isolated rat hepatic stellate cells , 1998, Hepatology.
[188] V. Ferrans,et al. Requirement for Generation of H2O2 for Platelet-Derived Growth Factor Signal Transduction , 1995, Science.
[189] B. Bacon,et al. Hepatic lipid peroxidation in vivo in rats with chronic iron overload. , 1983, The Journal of clinical investigation.
[190] A. Gressner,et al. Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. A potential mechanism of self perpetuation in liver fibrogenesis. , 1992, The Journal of clinical investigation.
[191] I. Sternlieb,et al. Copper and the liver. , 1980, Gastroenterology.
[192] S. Friedman,et al. DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells. , 2001, The Journal of clinical investigation.
[193] A. Pietrangelo,et al. Molecular and cellular aspects of iron-induced hepatic cirrhosis in rodents. , 1995, The Journal of clinical investigation.
[194] B. Portmann,et al. Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection. , 1995, Gastroenterology.
[195] A. Rivas-Estilla,et al. Hydrogen peroxide: A link between acetaldehyde‐elicited α1(i) collagen gene up‐regulation and oxidative stress in mouse hepatic stellate cells , 2000, Hepatology.
[196] J. Morrow,et al. Identification of platelet-activating factor as the inflammatory lipid mediator in CCl4-metabolizing rat liver. , 2001, Journal of lipid research.
[197] I. Issemann,et al. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators , 1990, Nature.
[198] A. Gressner,et al. Modulation of hepatic lipocyte proteoglycan synthesis and proliferation by Kupffer cell-derived transforming growth factors type β1 and type α , 1990 .
[199] M. Sporn,et al. Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[200] A. Cederbaum,et al. Induction of catalase, alpha, and microsomal glutathione S‐transferase in CYP2E1 overexpressing HepG2 cells and protection against short‐term oxidative stress , 2001, Hepatology.
[201] G. Vendemiale,et al. Hepatic glutathione content in patients with alcoholic and non alcoholic liver diseases. , 1988, Life sciences.
[202] J. Prieto,et al. Tumor necrosis factor α gene expression and the response to interferon in chronic hepatitis C , 1996, Hepatology.
[203] E. González‐Reimers,et al. Cytokine levels in acute alcoholic hepatitis: a sequential study. , 1995, Drug and alcohol dependence.
[204] G. Gores,et al. Liver cell necrosis: cellular mechanisms and clinical implications. , 1995, Gastroenterology.
[205] D. Fuchs,et al. Neopterin and soluble tumor necrosis factor receptor type I in alcohol‐induced cirrhosis , 1995, Hepatology.
[206] D. Schuppan,et al. Acetaldehyde regulates the gene expression of matrix-metalloproteinase-1 and -2 in human fat-storing cells. , 1994, Life sciences.
[207] R. Evans,et al. Corepressors and nuclear hormone receptor function. , 2001, Current topics in microbiology and immunology.
[208] Y. Hasumura,et al. The Role of Fat‐Storing Cells in Disse Space Fibrogenesis in Alcoholic Liver Disease , 2007, Hepatology.
[209] M. Shibuya,et al. Expressions of vascular endothelial growth factor in nonparenchymal as well as parenchymal cells in rat liver after necrosis. , 1999, Biochemical and biophysical research communications.
[210] S. Seki,et al. Effect of antioxidants, resveratrol, quercetin, and N‐acetylcysteine, on the functions of cultured rat hepatic stellate cells and kupffer cells , 1998, Hepatology.
[211] P. Muriel. Alpha-interferon prevents liver collagen deposition and damage induced by prolonged bile duct obstruction in the rat. , 1996, Journal of hepatology.